Package 68788-6896-1

{"route": ["ORAL"], "spl_id": "7c60d1d2-a924-4118-9d74-b5c5d0c4d0a9", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["c153155b-69dc-41b7-91d2-0949ec496174"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (68788-6896-1)", "package_ndc": "68788-6896-1", "marketing_start_date": "20170213"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-6896-2)", "package_ndc": "68788-6896-2", "marketing_start_date": "20170213"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-6896-3)", "package_ndc": "68788-6896-3", "marketing_start_date": "20170213"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (68788-6896-4)", "package_ndc": "68788-6896-4", "marketing_start_date": "20170213"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE (68788-6896-6)", "package_ndc": "68788-6896-6", "marketing_start_date": "20170213"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (68788-6896-7)", "package_ndc": "68788-6896-7", "marketing_start_date": "20170213"}], "brand_name": "Valacyclovir hydrochloride", "product_id": "68788-6896_7c60d1d2-a924-4118-9d74-b5c5d0c4d0a9", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-6896", "generic_name": "Valacyclovir hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA077135", "marketing_category": "ANDA", "marketing_start_date": "20170213", "listing_expiration_date": "20261231"}